
WuXi Biologics Begins Construction of Microbial CDMO Site in Chengdu
WuXi Biologics, a global Contract Research, Development and Manufacturing Organization (CRDMO), has announced the start of construction on its new microbial manufacturing facility in Chengdu’s Wenjiang district. The site, spanning 95,000 square metres, will serve as a commercial drug substance